Advanced Biomed (ADVB) Total Current Liabilities (2024 - 2026)

Advanced Biomed (ADVB) has 3 years of Total Current Liabilities data on file, last reported at $1.4 million in Q1 2026.

• Quarterly Total Current Liabilities fell 65.34% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 65.34% YoY) and the FY2025 annual result came in at $10.1 million, up 269.43% from the prior year.
• Total Current Liabilities improved to $1.4 million in Q1 2026 per ADVB's latest filing, from $1.3 million in the prior quarter.
• The five-year high for Total Current Liabilities was $10.1 million in Q2 2025, with the low at $1.3 million in Q4 2025.
• Average Total Current Liabilities over 3 years is $3.8 million, with a median of $3.0 million recorded in 2025.
• The widest YoY moves for Total Current Liabilities: up 269.43% in 2025, down 67.26% in 2025.
• Advanced Biomed's Total Current Liabilities stood at $3.8 million in 2024, then tumbled by 67.26% to $1.3 million in 2025, then gained by 13.73% to $1.4 million in 2026.
• Business Quant data shows ADVB's Total Current Liabilities at $1.4 million in Q1 2026, $1.3 million in Q4 2025, and $3.0 million in Q3 2025.